Cost Effectiveness of First-Line Oral Therapies for Pulmonary Arterial Hypertension: A Modelling Study

BACKGROUND: In recent years, a significant number of costly oral therapies have become available for the treatment of pulmonary arterial hypertension (PAH). Funding decisions for these therapies requires weighing up their effectiveness and costs. OBJECTIVE: The aim of this study was to assess the co...

Descripción completa

Detalles Bibliográficos
Autores principales: Coyle, Kathryn, Coyle, Doug, Blouin, Julie, Lee, Karen, Jabr, Mohammed F., Tran, Khai, Mielniczuk, Lisa, Swiston, John, Innes, Mike
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4828471/
https://www.ncbi.nlm.nih.gov/pubmed/26739957
http://dx.doi.org/10.1007/s40273-015-0366-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4828471/
https://www.ncbi.nlm.nih.gov/pubmed/26739957
http://dx.doi.org/10.1007/s40273-015-0366-8

Ejemplares similares